Hep B vaccination rates for newborns have declined sharply, fueling renewed debate over safety, ethics, and public health policy. A canceled CDC-backed study in Guinea-Bissau has intensified scrutiny from both critics and vaccine advocates.
May 9, 2026
Hep B vaccination rates for newborns have declined sharply, fueling renewed debate over safety, ethics, and public health policy. A canceled CDC-backed study in Guinea-Bissau has intensified scrutiny from both critics and vaccine advocates.